Chemoinformaics analysis of 6-Hexyltetrahydro-2H-pyran-2-one
| Molecular Weight | 184.279 | nRot | 5 |
| Heavy Atom Molecular Weight | 164.119 | nRig | 7 |
| Exact Molecular Weight | 184.146 | nRing | 1 |
| Solubility: LogS | -3.435 | nHRing | 1 |
| Solubility: LogP | 3.571 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 33.3099 |
| nHD | 0 | BPOL | 22.6681 |
| QED | 0.485 |
| Synth | 2.614 |
| Natural Product Likeliness | 1.721 |
| NR-PPAR-gamma | 0.968 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.954 |
| Pgp-sub | 0.004 |
| HIA | 0.003 |
| CACO-2 | -4.51 |
| MDCK | 0.0000371 |
| BBB | 0.852 |
| PPB | 0.92589 |
| VDSS | 0.686 |
| FU | 0.0757965 |
| CYP1A2-inh | 0.38 |
| CYP1A2-sub | 0.365 |
| CYP2c19-inh | 0.143 |
| CYP2c19-sub | 0.182 |
| CYP2c9-inh | 0.09 |
| CYP2c9-sub | 0.893 |
| CYP2d6-inh | 0.088 |
| CYP2d6-sub | 0.304 |
| CYP3a4-inh | 0.296 |
| CYP3a4-sub | 0.193 |
| CL | 7.869 |
| T12 | 0.628 |
| hERG | 0.024 |
| Ames | 0.013 |
| ROA | 0.013 |
| SkinSen | 0.943 |
| Carcinogencity | 0.492 |
| EI | 0.902 |
| Respiratory | 0.253 |
| NR-Aromatase | 0.037 |
| Antiviral | No |
| Prediction | 0.639029 |